FIELD: medicine.
SUBSTANCE: method involves determining homocystein level in venous blood plasma. The value being found 2.2 times as high as a reference value, severe gestosis is to be diagnosed.
EFFECT: high accuracy of diagnosis.
1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF THE RISK OF DEVELOPING SEVERE COMPLICATIONS OF PREECLAMPSIA | 2020 |
|
RU2741730C1 |
DIAGNOSTIC TECHNIQUE FOR SEVERE GESTOSIS | 2011 |
|
RU2476880C1 |
METHOD FOR PREDICTION OF DEVELOPING SEVERE PREECLAMPSIA | 2012 |
|
RU2481578C1 |
METHOD OF DIAGNOSING SEVERE PREECLAMPSIA | 2015 |
|
RU2587781C1 |
METHOD OF PROLONGING PREGNANCY IN EARLY PRE-ECLAMPSIA | 2023 |
|
RU2803574C1 |
DIAGNOSTIC TECHNIQUE OF PREECLAMPSIA IN PREGNANT WOMEN WITH CHRONIC ARTERIAL HYPERTENSION | 2012 |
|
RU2483311C1 |
METHOD OF MORPHOLOGICAL DIAGNOSIS OF THE SEVERITY OF PREECLAMPSIA | 2017 |
|
RU2682251C1 |
METHOD FOR FORECASTING DEVELOPMENT OF PRE-ECLAMPSIA IN LATE PREGNANCY | 2018 |
|
RU2691114C1 |
METHOD FOR PREECLAMPSIA SEVERITY ASSESSMENT BY RELATIVE CONTENT OF CD16+ MONOCYTES IN PERIPHERAL BLOOD OF PREGNANT WOMEN | 2019 |
|
RU2712228C1 |
METHOD OF DIFFERENTIAL DIAGNOSTICS OF HYPERTENSIVE DISORDERS DURING PREGNANCY | 2010 |
|
RU2444280C2 |
Authors
Dates
2005-08-27—Published
2003-06-06—Filed